Journal Home
Search for

Volume 55, Issue 2, Pages 344-347 (February 2010)


View previous. 32 of 39 View next.

Successful Treatment With Retinoids in Patients With Lupus Nephritis

Koji Kinoshita, MD, PhDCorresponding Author Informationemail address, Kazuya Kishimoto, MD, Hideki Shimazu, MD, Yuji Nozaki, MD, PhD, Masafumi Sugiyama, MD, PhD, Shinya Ikoma, MD, PhD, Masanori Funauchi, MD, PhD

Received 18 March 2009; accepted 8 June 2009. published online 24 July 2009.

Lupus nephritis is a major manifestation of systemic lupus erythematosus. Treatment with such immunosuppressive agents as corticosteroids or cyclophosphamide can decrease the progression of lupus nephritis; however, these agents have potentially severe adverse reactions. Therefore, the development of new drugs with fewer side effects is needed. Here, we report 2 patients with lupus that were treated successfully with retinoids. Initially, both patients were treated with 60 mg/d of prednisolone. However, nephrotic syndrome was not improved. Subsequently, treatment with 10 mg/d of all-trans-retinoic acid was started orally and elicited a good response, showing a decrease in proteinuria. Although additional controlled clinical studies are needed to confirm these findings, we suggest that therapy using retinoids may represent a novel approach to the treatment of patients with lupus nephritis.

Index WordsLupus, retinoid, nephritis

Department of Nephrology and Rheumatology, Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan

Corresponding Author InformationAddress correspondence to Koji Kinoshita, MD, PhD, Department of Nephrology and Rheumatology, Kinki University School of Medicine, 377-2 Ohno-Higashi, Osaka-Sayama, Osaka, 589-8511, Japan

 Originally published online as doi:10.1053/j.ajkd.2009.06.012 on July 24, 2009.

PII: S0272-6386(09)00875-0

doi:10.1053/j.ajkd.2009.06.012


View previous. 32 of 39 View next.